Thought of the Week: Count Your Life
May 27, 2025
Thought of the Week: The Real Lessons
Related:
Thought of the Week: Love Protects
May 19, 2025
Thought of the Week: Special Joy
May 11, 2025
Thought of the Week: Adjust Your Sails
May 5, 2025
Thought of the Week: Perseverance & Spirit
April 24, 2025
Thought of the Week: Twice the Presence
April 17, 2025
Email me when people comment
Login
0 Comments
Edited by:
P. Berger
Caring for dementias such as Alzheimer's among family and friends, Peter committed to help preserve the dignity of people affected by Alzheimer's. AlzheimersWeekly.com is the fruit of that commitment.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Drugs
Alzheimer’s Drug Leqembi Gets Full FDA and MEDICARE Approval
First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.
No Comments
Research
Alzheimer’s Lethargy Due to Neurodegeneration, Not Insomnia
The tendency of Alzheimer’s patients to sleep throughout the day is not due to nighttime insomnia — it has to do with the degeneration of a type of neuron, according to a research study.
No Comments
Diet
Rosemary Emulates Aricept & Donepezil
Aricept® (generic: donepezil) treats Alzheimer’s by blocking AChE. Rosemary does that naturally. Learn about rosemary’s dementia-fighting benefits from Dr. J. Duke.
3 Comments
Drugs
Leqembi: Europe Checks It’s Safety; U.S. Approves Monthly Doses
The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On